TOTAL VOLUME:

$154.8b

24H VOL:

$277,138,640

24H TRANSACTIONS:

2,984,640,614

OPEN INTEREST:

$1,905,404,943

412,077

Markets across

39,838

events

MATCHED EVENTS:

4,526

PLATFORM COVERAGE:

5

Polymarket:

37%

VS.

Kalshi:

63%

BETA
Dashboards
Insights
Indices
API
Tour
All
Trending
Breaking
New
Ending Soon
Politics
Sports
Elections
Crypto
Companies
Financials
Economics
Other
Entertainment
Science and Technology
Will Humana (HUM) beat quarterly earnings?
polymarket

Will Humana (HUM) beat quarterly earnings?

Oct 26, 2026, 8:07 PM EST - Nov 6, 2026, 9:00 AM EST
Total volume:
$759
Volume 24h:
$0N/A
Liquidity:
$338
5%
Open interest:
$373N/A

Will Humana (HUM) beat quarterly earnings?

 - Polymarket

Will Humana (HUM) beat quarterly earnings? - Polymarket

1W

News

Positive

Negative

Neutral

Hover marker for details

Vol.

·

Resolves Nov 6, 2026

Time left: 03d:07h:39m

Will Humana (HUM) beat quarterly earnings?

80%chance
Amount

$

Trade on
polymarket

Trade on Polymarket

At 93¢ buys you 108 shares | Odds: 80% Total Payout: $108 | Net Profit: $8 Multiplier: 1.08x | ROI: 8% APY not meaningful Low liquidity 3 days to resolution
You will be redirected to the platform to complete this trade.
Outcome
Trade
Chance %
Price
Spread
Liquidity
Volume
24h
7d
Open Interest
Ends in
Result
polymarket

Will Humana (HUM) beat quarterly earnings?

Trade
80%
Yes 93¢No 33¢
26¢
$338
$759
0%
N/A
N/A
3d 7h 39m
Active
Total markets: 1

Description

As of market creation, Humana is estimated to release earnings on November 6, 2026. The Street consensus estimate for Humana’s non-GAAP EPS for the relevant quarter is $-1.01 as of market creation. This market will resolve to "Yes" if Humana reports non-GAAP EPS greater than $-1.01 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If Humana releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets reflect the selected street consensus estimate for non-GAAP EPS as of market creation. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.

Polymarket

As of market creation, Humana is estimated to release earnings on November 6, 2026. The Street consensus estimate for Humana’s non-GAAP EPS for the relevant quarter is $-1.01 as of market creation. This market will resolve to "Yes" if Humana reports non-GAAP EPS greater than $-1.01 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If Humana releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets reflect the selected street consensus estimate for non-GAAP EPS as of market creation. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.

Frequently asked questions

On Polymarket, the dashboard for the Humana earnings market tracks the current odds of Humana beating quarterly earnings, the price history of the market, and the 24-hour trading volume. Currently, the volume is $125. You can also see the total volume traded to date, which is $759. This allows traders to monitor market sentiment and activity related to Humana’s financial performance. The dashboard provides a real-time view of how the crowd is predicting the outcome, offering insight into expectations before the official earnings release.

Currently, prediction market participants are indicating a 80.0% probability that Humana will beat quarterly earnings. This differs from traditional analyst forecasts, which often rely on modeling and company guidance. It’s common to see discrepancies between these sources, as prediction markets incorporate a wider range of information and reflect the collective wisdom of a diverse group of traders. This market provides an alternative perspective on the likelihood of a positive earnings surprise, potentially capturing factors not fully considered in standard financial analysis.

On Polymarket, this market is priced through a continuous auction mechanism where traders buy and sell shares representing their belief about whether Humana will beat quarterly earnings. The price of a share directly reflects the probability of that outcome occurring, as perceived by the market participants. On Polymarket, prices reflect that venue's order book, liquidity, and how traders price the outcome right now. The market’s price adjusts dynamically based on supply and demand, meaning that increased buying pressure will raise the price, indicating growing confidence in a positive earnings report, and vice versa. This creates a real-time assessment of expectations.

This market resolves around Nov 6, 2026, with the outcome confirmed once the event is verifiable from credible public reporting. Specifically, the resolution will be based on whether Humana’s reported earnings per share (EPS) exceed the consensus EPS estimate of financial analysts at the time of the earnings release. The official earnings report from Humana will serve as the basis for determining the winning outcome in this market, providing a transparent and objective resolution process.

Several signals could significantly impact this market before its resolution. Any news related to Humana’s business performance, such as changes in membership numbers, healthcare policy updates, or competitor announcements, could influence trader sentiment. Additionally, broader economic indicators, like inflation data or interest rate decisions, may affect the overall market outlook for healthcare companies. Finally, revisions to analyst earnings estimates for Humana could also trigger price movements in this market, as traders adjust their expectations based on new information.